- Home
- INBK vs ENTX Comparison
INBK vs ENTX Comparison
Compare INBK & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBK | ENTX |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.2M | 142.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | INBK | ENTX |
|---|---|---|
| Price | $20.47 | $1.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $28.67 | $10.00 |
| AVG Volume (30 Days) | 60.7K | ★ 113.2K |
| Earning Date | 01-21-2026 | 11-14-2025 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,731,000.00 | $124,000.00 |
| Revenue This Year | $4.47 | N/A |
| Revenue Next Year | $25.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 25.25 |
| 52 Week Low | $17.05 | $1.50 |
| 52 Week High | $37.50 | $3.22 |
Technical Indicators
Market Signals| Indicator | INBK | ENTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.80 | 30.09 |
| Support Level | $19.56 | $1.69 |
| Resistance Level | $23.13 | $2.22 |
| Average True Range (ATR) | 0.85 | 0.14 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 26.85 | 19.28 |
Price Performance
Historical ComparisonAbout INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.